OncoMatch/Clinical Trials/Pancreatic Cancer (PDAC)
Pancreatic Cancer (PDAC) Clinical Trials
OncoMatch filters Pancreatic Cancer (PDAC) trials by the molecular markers that determine eligibility — BRCA1, BRCA2, KRAS, MMR, and more. Enter your biomarker results to see only the trials you may qualify for.
Compare eligibility criteriaBiomarkers tested in Pancreatic Cancer (PDAC) trials
These are the molecular markers most commonly required or evaluated in Pancreatic Cancer (PDAC) eligibility criteria. OncoMatch extracts them from each trial's protocol and matches them against your test results.
Top recruiting Pancreatic Cancer (PDAC) trials
Ranked by phase and number of US sites. See all trials matched to your profile →
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
SWOG Cancer Research Network
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
NRG Oncology
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
Bristol-Myers Squibb
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Pfizer
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Panbela Therapeutics, Inc.
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Astellas Pharma Global Development, Inc.
How OncoMatch finds Pancreatic Cancer (PDAC) trials for you
AI reads the protocol
Every Pancreatic Cancer (PDAC) trial on ClinicalTrials.gov has eligibility criteria written for regulators. OncoMatch uses large language models to extract the structured requirements — biomarkers, stage, prior therapy, and more — from that text.
You enter your results
Select Pancreatic Cancer (PDAC) and mark your biomarker results — BRCA1, BRCA2, KRAS — as positive, negative, or not tested. Your data never leaves your device.
See only relevant trials
Results filter instantly. Each trial shows exactly which criteria you meet, which you don't, and which need more information. Bring the list to your oncologist.